For all the promise that 3D printing holds for manufacturing, the technology is fraught with uncertainty when it comes to the medical field. Looking to quell some of that concern the U.S. Food and Drug Administration will hold a two-day workshop to discuss the future of regulating 3D printed devices and procedures.
SIWW 2014
Booth # B2-B24
SINGAPORE---June 1, 2014---GE (NYSE: GE) will showcase its advanced energy-saving and efficient technologies, products and services designed to help industrial and municipal customers meet their toughest water challenges at Singapore International Water Week 2014, taking place June 1-5, 2014, in Singapore.
Solution helps enable patients' access to collaborative and subspecialty pathology services
Mississauga, ON -- June 1, 2014 -- GE Healthcare today announced that the OmnyxTM Integrated Digital Pathology (IDP) solution with the new VL120 high volume scanner has obtained a Health Canada Class II Medical Device License for primary diagnostic use. The OmnyxTM IDP with VL4 scanner was licensed in 2013 and has been developed by Omnyx, LLC, a joint venture of GE Healthcare and UPMC.
SHANNON, Ireland, May 30, 2014 -- GE Capital Aviation Services Limited (GECAS), the commercial aircraft leasing arm of GE, today announced that its engine leasing unit completed a purchase-and-leaseback transaction with Aerovías De Mexico S.A.de C.V., (Aeromexico), for a new GEnx engine. The engine will be used as a spare to support the airline's Boeing 787 fleet.
This week on Txchnologist, we watched art meet science and were reminded that human engineers still have much to learn from evolution.
GE Healthcare and Real Time Medical Partner to Further Empower Pathologists, Helping Improve Speed and Accuracy of Diagnosis
PITTSBURGH, PA -- May 30, 2014 -- GE Healthcare announced today a strategic partnership with Real Time Medical, an award-winning developer of workflow management software solutions. The agreement will allow GE Healthcare to offer a streamlined workflow that seamlessly connects pathologists and other clinicians, facilitating collaboration to help enhance accuracy and speed of diagnosis.
Princeton, NJ -- May 30, 2014 -- Effective from June 1st 2014 and following approval by the US Food and Drug Administration (FDA), GE Healthcare today announced the intent to supply generators for the production of sodium pertechnetate; technetium (Tc99m) injection to its radiopharmacies in the US.
